Alkermes Quarterly Balance Sheet
NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alkermes financial position
As of Jun 30, 2026, Alkermes reported total assets of $4.39 billion, up 95.0% from a year earlier against total liabilities of $2.58 billion. Shareholders' equity stood at $1.81 billion, or 41.2% of assets. The company held $511.5 million in cash and equivalents against $1.50 billion of debt, a net debt position of $991.6 million.
The current ratio (current assets divided by current liabilities) was 2.30, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.83.
Summary generated from market data by MetaCap's automated system. Methodology
Alkermes balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 511.53M | 351.55M | 388.57M | 616.45M | 521.20M | 399.81M | 291.15M | 396.29M | 535.15M | 420.75M | 457.47M | 647.71M |
| Short-Term Investments | 145.05M | 160.31M | 199.65M | 494.67M | 494.54M | 484.21M | 460.52M | 512.57M | 340.97M | 324.30M | 316.02M | 241.44M |
| Receivables | 456.48M | 407.63M | 334.02M | 354.39M | 354.91M | 318.70M | 384.53M | 367.21M | 366.42M | 315.85M | 332.48M | 337.70M |
| Inventory | 298.96M | 336.70M | 196.63M | 191.00M | 191.92M | 183.44M | 182.89M | 191.09M | 194.73M | 198.37M | 186.41M | 192.19M |
| Total Current Assets | 1.52B | 1.36B | 1.93B | 1.74B | 1.64B | 1.48B | 1.42B | 1.56B | 1.54B | 1.47B | 1.49B | 1.46B |
| Property, Plant & Equipment | 218.28M | 220.59M | 221.72M | 246.98M | 239.40M | 233.92M | 227.56M | 225.42M | 222.74M | 224.59M | 226.94M | 327.52M |
| Goodwill | 594.27M | 596.03M | 83.03M | — | — | — | 83.03M | 83.03M | 83.03M | 83.03M | 83.03M | 92.87M |
| Intangible Assets | 1.76B | 1.78B | 815.00K | — | — | — | 890.00K | 904.00K | 918.00K | 932.00K | 1.99M | 10.99M |
| Long-Term Investments | 35.05M | 26.36M | 145.00K | 27.87M | 38.27M | 32.19M | 73.15M | 18.92M | 86.40M | 62.78M | 39.89M | 106.43M |
| Total Assets | 4.39B | 4.26B | 2.49B | 2.33B | 2.25B | 2.08B | 2.06B | 2.16B | 2.21B | 2.12B | 2.14B | 2.28B |
| Accounts Payable | 142.86M | 102.36M | 107.95M | 68.00M | 99.21M | 59.84M | 45.63M | 37.04M | 104.75M | 77.05M | 65.65M | 87.04M |
| Short-Term Debt | 26.50M | 26.50M | 0 | — | — | — | — | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Total Current Liabilities | 662.09M | 599.50M | 543.44M | 474.36M | 505.96M | 443.73M | 465.20M | 453.70M | 515.55M | 458.98M | 520.22M | 503.11M |
| Long-Term Debt | 1.48B | 1.48B | 0 | — | — | — | — | 285.82M | 286.46M | 287.10M | 287.73M | 288.37M |
| Total Liabilities | 2.58B | 2.51B | 667.70M | 596.08M | 628.23M | 570.39M | 590.59M | 863.18M | 922.84M | 869.13M | 933.54M | 923.65M |
| Shareholders' Equity | 1.81B | 1.75B | 1.82B | 1.73B | 1.62B | 1.51B | 1.46B | 1.29B | 1.28B | 1.25B | 1.20B | 1.36B |
| Retained Earnings | -800.77M | -801.27M | -734.79M | -784.13M | -866.90M | -953.99M | -976.46M | -1.12B | -1.22B | -1.31B | -1.34B | -1.46B |
| Total Debt | 1.50B | 1.51B | 0 | — | — | — | — | 288.82M | 289.46M | 290.10M | 290.73M | 291.37M |
| Net Cash (Debt) | -846.53M | -998.48M | 588.22M | 1.11B | 1.02B | 884.02M | 751.67M | 620.04M | 586.66M | 454.95M | 482.76M | 597.78M |
| Shares Outstanding | 167.54M | 166.46M | 165.61M | 165.10M | 165.05M | 164.85M | 162.18M | 161.78M | 165.89M | 169.18M | 166.98M | 166.71M |
This table shows 12 quarterly periods of Alkermes's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ALKS's reporting calendar. What is a balance sheet?